L1210 |
ID50 |
> |
1000.0 |
ug ml-1 |
Cytostatic activity against proliferation of L1210/0 cells (murine leukemia L1210 cells) |
CHEMBL1123152 |
L1210 |
ID50 |
> |
1000.0 |
ug ml-1 |
Cytostatic activity against proliferation of L1210/BdU cells (deoxythymidine kinase deficient L1210 cells) |
CHEMBL1123152 |
Raji |
ID50 |
> |
1000.0 |
ug ml-1 |
Cytostatic activity against proliferation of Raji/0 cells (human lymphoblast Raji cells) |
CHEMBL1123152 |
Raji |
ID50 |
= |
612.0 |
ug ml-1 |
Cytostatic activity against proliferation of Raji/TK cells (deoxythymidine kinase deficient Raji cells) |
CHEMBL1123152 |
No relevant target |
LogP |
= |
0.04 |
|
Partition coefficient (logP) |
CHEMBL1123071 |
Dihydropyrimidine dehydrogenase |
IC50 |
= |
220.0 |
nM |
Inhibitory activity against dihydropyrimidine dehydrogenase (DPD) |
CHEMBL1136621 |
No relevant target |
Retention_time |
= |
8.85 |
min |
Retention time of the compound by liquid chromatography |
CHEMBL3244133 |
Replicase polyprotein 1ab |
Inhibition |
= |
22.91 |
% |
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate |
CHEMBL4495564 |
SARS-CoV-2 |
Inhibition |
= |
0.08 |
% |
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging |
CHEMBL4495565 |
SARS-CoV-2 |
Inhibition |
= |
0.08 |
% |
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging |
CHEMBL4495565 |